AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples